A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
Article in Journal of Virology (April 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in Journal of Virology (April 2024)
Article in npj Vaccines (October 2022)
Article in EBioMedicine (January 2022)